文献速递药疹与重症皮肤不良反应

药物诱导的Stevens-Johnson综合征/中毒性表皮坏死松解症中血清及疱液HMGB1升高而表皮含量降低

Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
PubMed 文献 · Br J Dermatol · 2019-03-26

研究检测了马拉维、台湾和西班牙SJS/TEN队列的血清及疱液总HMGB1水平,并比较了SJS/TEN、健康及斑丘疹药疹皮肤的HMGB1表达。结果:台湾SJS/TEN急性期血清HMGB1显著高于极期和恢复期;西班牙SJS/TEN疱液HMGB1显著高于血清;SJS/TEN皮损表皮上部核HMGB1表达较健康或MPE皮肤降低,但基底层/基底层上方表达保留。

要点

  • 台湾SJS/TEN患者急性期血清HMGB1为32.6±26.6 ng/mL,显著高于极期19.7±23.2 ng/mL(P=0.007)和恢复期24.6±25.3 ng/mL(P=0.027)。
  • 西班牙SJS/TEN患者疱液HMGB1为486.8±687.9 ng/mL,显著高于血清8.8±7.6 ng/mL(P<0.001)。
  • SJS/TEN皮损表皮上部核HMGB1表达较健康或MPE皮肤降低,但基底层/基底层上方表达保留。

核心结论

  • SJS/TEN皮肤表皮HMGB1表达降低,保留的基底层/基底层上方表皮HMGB1表达可能加重SJS/TEN的局部损伤。

研究设计与样本

  • 研究检测马拉维奈韦拉平诱导超敏反应、台湾SJS/TEN和西班牙SJS/TEN队列的血清HMGB1,并对健康皮肤、MPE和SJS/TEN的FFPE皮肤进行HMGB1染色评估。

主要发现

  • 奈韦拉平诱导SJS/TEN患者血清总HMGB1为3.98±2.17 ng/mL,MPE为3.92±2.75 ng/mL,伴嗜酸性粒细胞增多和全身症状的药疹为4.73±3.00 ng/mL,耐受对照为2.97±3.00 ng/mL,组间无显著差异。
  • 台湾SJS/TEN患者血清HMGB1在急性期为32.6±26.6 ng/mL,显著高于极期19.7±23.2 ng/mL(P=0.007)和恢复期24.6±25.3 ng/mL(P=0.027)。
  • 西班牙SJS/TEN患者疱液HMGB1为486.8±687.9 ng/mL,显著高于血清8.8±7.6 ng/mL(P<0.001)。
  • SJS/TEN水疱形成前皮肤表皮上部核HMGB1表达较健康或MPE皮肤降低,但基底层/基底层上方表达保留。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-mobility group box 1 (HMGB1) is a damage-associated molecular-pattern protein. Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) are serious, immune-mediated skin-blistering conditions. OBJECTIVES: To determine serum and/or blister-fluid total HMGB1 levels in SJS/TEN cohorts, and HMGB1 expression in formalin-fixed, paraffin-embedded (FFPE) SJS/TEN skin vs. healthy and maculopapular exanthema (MPE) skin. Methods Serum HMGB1 was quantified in Malawian nevirapine-induced hypersensitivity, Taiwanese SJS/TEN and Spanish SJS/TEN cohorts. FFPE skin (healthy skin, MPE, SJS/TEN) was stained and assessed for HMGB1 expression. RESULTS: Serum total HMGB1 was not significantly elevated in patients with nevirapine-induced SJS/TEN (3·98 ± 2·17 ng mL-1 ), MPE (3·92 ± 2·75 ng mL-1 ) or drug reaction with eosinophilia and systemic symptoms (4·73 ± 3·00 ng mL-1 ) vs. tolerant controls (2·97 ± 3·00 ng mL-1 ). HMGB1 was significantly elevated in Taiwanese patients with SJS/TEN, highest during the acute phase (32·6 ± 26·6 ng mL-1 ) vs. the maximal (19·7 ± 23·2 ng mL-1 ; P = 0·007) and recovery (24·6 ± 25·3 ng mL-1 ; P = 0·027) phases. In blister fluid from Spanish patients with SJS/TEN, HMGB1 (486·8 ± 687·9 ng mL-1 ) was significantly higher than in serum (8·8 ± 7·6 ng mL-1 ; P <0·001). Preblistered SJS/TEN skin showed decreased epidermal nuclear HMGB1 expression in upper epidermis vs. healthy or MPE skin but retained basal/suprabasal expression. CONCLUSIONS: Epidermal HMGB1 expression was decreased in SJS/TEN skin. Retained basal/suprabasal epidermal HMGB1 expression may exacerbate localized injury in SJS/TEN.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Carr DF, Wang CW, Bellón T, et al. Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol. 2019. PMID: 30613954. doi:10.1111/bjd.17610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。